BIOPOR Bioporto A/S

Share capital and votes

Share capital and votes

April 30, 2020

Announcement no. 12

Share capital and votes

Pursuant to section 32 of the Danish Capital Markets Act, BioPorto’s nominal share capital totals DKK 199,936,428 consisting of 199,936,428 shares of DKK 1.00, equivalent to 199,936,428 votes. BioPorto’s Articles of Association have been updated accordingly and are available on

For further information, please contact:

Ole Larsen, CFO

Telephone , e-mail:

About BioPorto

BioPorto is an in vitro diagnostics company that provides tests and antibodies to clinicians and researchers around the world. We use our antibody and assay expertise to transform novel research tools into clinically actionable biomarkers that can make a difference in patients’ lives. BioPorto is headquartered in Hellerup, Denmark and is listed on the NASDAQ Copenhagen stock exchange [CPH:BIOPOR].

Attachment

EN
30/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bioporto A/S

 PRESS RELEASE

Ændringer i selskabets Direktion

Ændringer i selskabets Direktion 11. december 2025 Meddelelse nr. 29 Ændringer i selskabets Direktion KØBENHAVN, DANMARK og BOSTON, MA, USA, 11. december 2025 (GLOBE NEWSWIRE) – BioPorto A/S ("BioPorto") (CPH:BIOPOR) meddelte i dag, at Niels Høy Nielsen har opsagt sin stilling som CFO for BioPorto for at tiltræde en CFO-stilling i et andet selskab. "Jeg har værdsat det tætte samarbejde med Niels i de sidste par måneder, siden jeg tiltrådte min stilling i BioPorto. Niels har ydet vigtige bidrag til virksomheden og jeg ønsker ham alt det bedste i hans fremtidige stilling," sagde Carsten B...

 PRESS RELEASE

Changes to the Executive Management

Changes to the Executive Management December 11, 2025 Announcement no. 29                                                                          Changes to the Executive Management COPENHAGEN, DENMARK and BOSTON, MA, USA, December 11, 2025 (GLOBE NEWSWIRE) – BioPorto A/S (“BioPorto”) (CPH:BIOPOR) announced today that Niels Høy Nielsen has resigned as CFO of BioPorto to become CFO at another company. “I have valued the close collaboration with Niels during the last couple of months since I joined BioPorto. He has made important contributions across the company and wish him all the bes...

 PRESS RELEASE

Ledende medarbejderes transaktioner

Ledende medarbejderes transaktioner 24. november 2025Meddelelse nr. 28                                                                          Ledende medarbejderes transaktioner I forbindelse med gennemførelsen af BioPorto A/S' rettede emission, som beskrevet i selskabsmeddelelse nr. 27, har BioPorto A/S i henhold til artikel 19 i forordning (EU) nr. 596/2014 modtaget indberetning af nedenstående transaktioner vedrørende aktier i BioPorto A/S foretaget af personer med ledelsesansvar i BioPorto A/S og/eller nærtstående til disse. 1 Nærmere oplysninger om personen med ledelsesansvar/pers...

 PRESS RELEASE

Managers’ transactions

Managers’ transactions  November 24, 2025Announcement no. 28                                                                          Managers’ transactions In connection with the completion of BioPorto A/S’ directed issue as described in company announcement no. 27, BioPorto A/S has received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below transactions related to shares in BioPorto A/S made by persons discharging managerial responsibilities in BioPorto A/S and/or persons closely associated with them. 1 Details of the person discharging managerial responsi...

 PRESS RELEASE

BioPorto A/S rejser ca. 43 mio. kr. i ny kapitalrunde - Ændring i anta...

BioPorto A/S rejser ca. 43 mio. kr. i ny kapitalrunde - Ændring i antal aktier og stemmer 24. november 2025 Meddelelse nr. 27                                                                          BioPorto A/S rejser ca. 43 mio. kr. i ny kapitalrunde - Ændring i antal aktier og stemmer Gennemførelse af kapitalforhøjelse København, Danmark, 24. november 2025, (GLOBE NEWSWIRE) - Bestyrelsen for BioPorto A/S ("BioPorto" eller "Selskabet") (CPH:BIOPOR) besluttede den 13. november 2025 at gennemføre en rettet emission af 40.438.426 nye aktier til eksisterende større aktionærer, nye instit...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch